WOODSTOCK CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOODSTOCK CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$409,631
-55.3%
116,704
-14.9%
0.05%
-59.1%
Q3 2023$916,356
-20.4%
137,1790.0%0.12%
-15.4%
Q2 2023$1,150,932
-15.5%
137,1790.0%0.14%
-21.8%
Q1 2023$1,362,187
+42.7%
137,1790.0%0.17%
+37.0%
Q4 2022$954,766
+38.4%
137,179
+6.2%
0.13%
+23.3%
Q3 2022$690,000
+65.1%
129,179
+23.3%
0.10%
+77.6%
Q2 2022$418,000
+32.3%
104,734
+47.5%
0.06%
+56.8%
Q1 2022$316,000
-75.7%
70,998
-52.1%
0.04%
-75.7%
Q3 2021$1,300,000
-22.5%
148,0720.0%0.15%
-22.8%
Q2 2021$1,678,000
-4.6%
148,0720.0%0.20%
-12.1%
Q1 2021$1,759,000
+73.1%
148,0720.0%0.22%
+64.7%
Q4 2020$1,016,000
-7.4%
148,0720.0%0.14%
-23.2%
Q3 2020$1,097,000
+77.8%
148,0720.0%0.18%
+68.6%
Q2 2020$617,000
+87.0%
148,072
+10.7%
0.10%
+56.7%
Q1 2020$330,000
-57.5%
133,7860.0%0.07%
-47.2%
Q4 2019$777,000
+49.1%
133,786
+35.4%
0.13%
+39.6%
Q3 2019$521,000
-12.1%
98,8410.0%0.09%
-12.5%
Q2 2019$593,000
-33.6%
98,8410.0%0.10%
-35.0%
Q1 2019$893,000
+19.4%
98,841
+9.7%
0.16%
+6.7%
Q4 2018$748,000
-20.0%
90,085
+32.9%
0.15%
-5.1%
Q3 2018$935,000
+73.5%
67,7590.0%0.16%
+59.6%
Q2 2018$539,000
+6.1%
67,7590.0%0.10%
+3.1%
Q1 2018$508,000
+28.3%
67,759
+16.3%
0.10%
+31.5%
Q4 2017$396,000
+13.8%
58,243
+20.4%
0.07%
+10.6%
Q3 2017$348,00048,3930.07%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,009,131$7,568,0001.15%
Knoll Capital Management, LLC 124,096$931,0000.96%
683 Capital Management, LLC 1,000,000$7,500,0000.66%
Perceptive Advisors 3,085,458$23,141,0000.65%
MANGROVE PARTNERS IM, LLC 324,019$2,430,0000.16%
Stanley-Laman Group, Ltd. 64,029$480,0000.11%
WOODSTOCK CORP 67,759$508,0000.10%
Hikari Power Ltd 107,858$809,0000.10%
ARDSLEY ADVISORY PARTNERS LP 45,000$336,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 750,000$5,625,0000.01%
View complete list of ALDEYRA THERAPEUTICS INC shareholders